Hepatitis B News and Research

Latest Hepatitis B News and Research

Treatment of chronic hepatitis C with interferon can be ineffective due to relapse

Treatment of chronic hepatitis C with interferon can be ineffective due to relapse

New research may help doctors diagnose diseases like HIV and hepatitis C earlier

New research may help doctors diagnose diseases like HIV and hepatitis C earlier

The EU is contributing €9 million to the “Vigilance against Viral Resistance” (VIRGIL) project

The EU is contributing €9 million to the “Vigilance against Viral Resistance” (VIRGIL) project

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

SARS, the highly infectious respiratory virus, has been found in tears

SARS, the highly infectious respiratory virus, has been found in tears

Harmless virus known as GBV-C slows the progression of HIV

Harmless virus known as GBV-C slows the progression of HIV

Australian researchers awarded funding for new HIV vaccines

Australian researchers awarded funding for new HIV vaccines

Call for special help for young people who inject drugs

Call for special help for young people who inject drugs

World Blood Donor Day

World Blood Donor Day

UK's Hepatitis C ex-gratia payment scheme to launch

UK's Hepatitis C ex-gratia payment scheme to launch

Breakthrough in gene therapy

Breakthrough in gene therapy

Tuberculosis test kits order

Tuberculosis test kits order

Myth of disease threat posed by dead bodies after natural disasters unfounded

Myth of disease threat posed by dead bodies after natural disasters unfounded

Marijuana use does not appear to be associated with an increased risk of developing oral cancer

Marijuana use does not appear to be associated with an increased risk of developing oral cancer

Treatment helps 26% of black Americans with chronic hepatitis C

Treatment helps 26% of black Americans with chronic hepatitis C

Blueprint for rational design of vaccines that induce desired T-cell responses

Blueprint for rational design of vaccines that induce desired T-cell responses

New study challenges current thinking about varied response to hepatitis C treatment in different racial groups

New study challenges current thinking about varied response to hepatitis C treatment in different racial groups

Human Genome Sciences has begun dosing patients with chronic hep C drug

Human Genome Sciences has begun dosing patients with chronic hep C drug

Health-care providers can now review and update immunization records for patients online

Health-care providers can now review and update immunization records for patients online

Canadian healthcare policy under the microscope

Canadian healthcare policy under the microscope

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.